(Q48383559)

11 February 2018

title

Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis. (English)

1 reference

11 February 2018

0 references

1 reference

Bowen JD

1

1 reference

11 February 2018

Petersdorf SH

2

1 reference

11 February 2018

Richards TL

3

1 reference

11 February 2018

Maravilla KR

4

1 reference

11 February 2018

Dale DC

5

1 reference

11 February 2018

Price TH

6

1 reference

11 February 2018

St John TP

7

1 reference

11 February 2018

Yu AS

8

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

11 February 2018

volume

64

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

339-346

1 reference

11 February 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Immunological aspects of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Adhesion receptors of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

Resolution of CNS lesions following treatment of experimental allergic encephalomyelitis in macaques with monoclonal antibody to the CD18 leukocyte integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

A neurologic rating scale (NRS) for use in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

QUANTITATIVE STUDIES OF THE LOCAL EXUDATIVE CELLULAR REACTION IN ACUTE LEUKEMIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

LAGRAN program for area and moments in pharmacokinetic analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990183-7

10.1016/S0009-9236(98)90183-7

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9757158

1 reference

11 February 2018